肾性骨营养不良的管理 - Suppr

Suppr

超能文献

The management of renal osteodystrophy.

作者信息

Salusky I B, Goodman W G

机构信息

Department of Pediatrics, UCLA School of Medicine, USA.

出版信息

Pediatr Nephrol. 1996 Oct;10(5):651-3. doi: 10.1007/s004670050183.

DOI:10.1007/s004670050183

PMID:8897578

Abstract

摘要

相似文献

The management of renal osteodystrophy.肾性骨营养不良的管理

Pediatr Nephrol. 1996 Oct;10(5):651-3. doi: 10.1007/s004670050183.

The treatment of renal osteodystrophy.肾性骨营养不良的治疗

Pediatr Nephrol. 1996 Oct;10(5):653-5. doi: 10.1007/s004670050184.

[Renal osteodystrophy].[肾性骨营养不良]

Chir Organi Mov. 1987 Apr-Jun;72(2):125-36.

Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.血液透析患者甲状旁腺激素测量用于评估肾性骨营养不良

Mt Sinai J Med. 1984 Apr;51(2):132-7.

Renal osteodystrophy.肾性骨营养不良

Am J Dis Child. 1979 Sep;133(9):891-3. doi: 10.1001/archpedi.1979.02130090019002.

Diseases of the urinary system. renal osteodystrophy.泌尿系统疾病。肾性骨营养不良。

Br Med J. 1977 Jul 9;2(6079):110-2. doi: 10.1136/bmj.2.6079.110.

PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.透析前慢性肾衰竭患者肾性骨营养不良的甲状旁腺激素及骨标志物

J Endocrinol Invest. 1992;15(9 Suppl 6):129-33.

[Subtotal parathyroidectomy in the treatment of renal osteodystrophy in 8 patients under chronic hemodialysis].

Rev Med Chil. 1984 Jun;112(6):564-9.

A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations.

Clin Chem. 2009 Sep;55(9):1737-9. doi: 10.1373/clinchem.2008.121921.

[Renal osteodystrophy].[肾性骨营养不良]

Z Urol Nephrol. 1986 Oct;79(10):595-602.

引用本文的文献

Interventions for metabolic bone disease in children with chronic kidney disease.慢性肾脏病患儿代谢性骨病的干预措施。

Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD008327. doi: 10.1002/14651858.CD008327.pub2.

Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?对于接受腹膜透析的肾切除婴儿，间歇性或每日给予1-α骨化醇？

Pediatr Nephrol. 2007 Nov;22(11):1931-8. doi: 10.1007/s00467-007-0592-1. Epub 2007 Sep 13.

Catch-up growth with normal parathyroid hormone levels in chronic renal failure.慢性肾衰竭中甲状旁腺激素水平正常时的追赶生长

Pediatr Nephrol. 2003 Dec;18(12):1236-41. doi: 10.1007/s00467-003-1284-0. Epub 2003 Oct 30.

Parathyroid hormone and its fragments in children with chronic renal failure.慢性肾功能衰竭患儿的甲状旁腺激素及其片段

Pediatr Nephrol. 2003 Dec;18(12):1242-8. doi: 10.1007/s00467-003-1267-1. Epub 2003 Oct 24.

Dialysis therapy in end-stage renal disease.

Indian J Pediatr. 1999 Mar-Apr;66(2):255-62. doi: 10.1007/BF02761216.

本文引用的文献

The spectrum of bone disease in end-stage renal failure--an evolving disorder.终末期肾衰竭骨病谱——一种不断演变的病症。

Kidney Int. 1993 Feb;43(2):436-42. doi: 10.1038/ki.1993.64.

Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism.

Kidney Int. 1993 Dec;44(6):1259-65. doi: 10.1038/ki.1993.377.

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function.无铝性再生障碍性骨营养不良：“受抑制的”甲状旁腺功能的作用

Kidney Int. 1993 Oct;44(4):860-6. doi: 10.1038/ki.1993.323.

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.接受持续性非卧床腹膜透析/持续循环腹膜透析的儿科患者肾性骨营养不良的生化标志物

Kidney Int. 1994 Jan;45(1):253-8. doi: 10.1038/ki.1994.31.

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.间歇性骨化三醇治疗后继发性甲状旁腺功能亢进患者动力缺失性骨病的发展

Kidney Int. 1994 Oct;46(4):1160-6. doi: 10.1038/ki.1994.380.

Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study.

Miner Electrolyte Metab. 1994;20(3):122-9.

Risk factors for renal osteodystrophy: a multivariant analysis.

J Bone Miner Res. 1995 Jan;10(1):149-56. doi: 10.1002/jbmr.5650100121.

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH.血液透析前、血液透析及持续性非卧床腹膜透析患者的骨病：对甲状旁腺激素有更好骨反应的证据。

Kidney Int. 1995 May;47(5):1434-42. doi: 10.1038/ki.1995.201.

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.静脉注射1,25 - 二羟胆钙化醇对尿毒症患者继发性甲状旁腺功能亢进有显著抑制作用。

J Clin Invest. 1984 Dec;74(6):2136-43. doi: 10.1172/JCI111639.

Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis.

J Pediatr. 1986 May;108(5 Pt 1):767-70. doi: 10.1016/s0022-3476(86)81064-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验